Dyadic International Inc. lost its $500 million lawsuit against Ernst & Young, but in the process it may have gotten help in pursuing Greenberg Traurig and other law firms it claims nearly destroyed the company.
Jupiter-based Dyadic, a biotechnology company that once traded on the AMEX, has been targeting Greenberg for malpractice damages since 2009.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
